These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15016555)

  • 21. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
    Cohen JS; Gross RL; Cheetham JK; VanDenburgh AM; Bernstein P; Whitcup SM
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S45-52. PubMed ID: 15016561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
    Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
    Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periocular cutaneous pigmentary changes associated with bimatoprost use.
    Galloway GD; Eke T; Broadway DC
    Arch Ophthalmol; 2005 Nov; 123(11):1609-10. PubMed ID: 16286629
    [No Abstract]   [Full Text] [Related]  

  • 25. Conjunctival hyperemia associated with bimatoprost use: a histopathologic study.
    Leal BC; Medeiros FA; Medeiros FW; Santo RM; Susanna R
    Am J Ophthalmol; 2004 Aug; 138(2):310-3. PubMed ID: 15289152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bimatoprost vs. timolol.
    Camras CB
    Ophthalmology; 2002 Apr; 109(4):627-8; author reply 628-9. PubMed ID: 11927409
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological considerations in the treatment of glaucoma.
    Fiscella RG
    Manag Care; 2002 Jan; 11(1 Suppl):16-20; discussion 24-7. PubMed ID: 11842587
    [No Abstract]   [Full Text] [Related]  

  • 28. A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients.
    Martin E; Martinez-de-la-Casa JM; Garcia-Feijoo J; Troyano J; Larrosa JM; Garcia-Sanchez J
    Eye (Lond); 2007 Feb; 21(2):164-8. PubMed ID: 16254590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of bimatoprost for the treatment of open-angle glaucoma and ocular hypertension: a three-month, open-label study in community-based practices in Thailand.
    Wanichwecha-Rungruang B; Iemsomboon W
    J Med Assoc Thai; 2005 Sep; 88(9):1228-35. PubMed ID: 16536109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy.
    Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G
    Am J Ophthalmol; 2006 Dec; 142(6):1059-60. PubMed ID: 17157592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N; Sahin A; Gultekin S
    J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients--a European perspective.
    Tuil E; Hommer AB; Poulsen PB; Christensen TL; Buchholz P; Walt J; Holmstrom S
    Int J Clin Pract; 2005 Sep; 59(9):1011-6. PubMed ID: 16115174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma.
    Kroll DM; Schuman JS
    Am J Ophthalmol; 2002 Mar; 133(3):401-3. PubMed ID: 11860979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy.
    Christensen TL; Poulsen PB; Holmstrom S; Walt JG; Vetrugno M
    Curr Med Res Opin; 2005 Nov; 21(11):1837-44. PubMed ID: 16307705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.
    Trattler W; Noecker RJ; Earl ML
    Adv Ther; 2008 Mar; 25(3):179-89. PubMed ID: 18351298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
    Varma R; Hwang LJ; Grunden JW; Bean GW
    Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent changes in glaucoma management].
    Tomita G
    Nippon Ganka Gakkai Zasshi; 2004 Apr; 108(4):191-2. PubMed ID: 15148733
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
    Simmons ST; Bernstein P; Hollander DA
    Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bimatoprost, the prodrug of a prostaglandin analogue.
    Camras CB; Sharif NA; Wax MB; Stjernschantz J
    Br J Ophthalmol; 2008 Jun; 92(6):862-3; author reply 863-4. PubMed ID: 18523093
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.